SPRC Company Profile and Key Details

Q: Who are the executives of SPRC?

Mr. Oz Adler C.P.A.Chief Executive Officer & Chief Financial OfficerDr. Adi Zuloff-Shani Ph.D.Chief Executive OfficerMr. Itschak ShremPres & DirectorMr. Oz Adler CPAChief Executive Officer & Chief Financial Officer

NASDAQ : SPRC

SciSparc

$4.23

-0.19-4.30%

At Close 4:00 PM

$6.30

4.23+48.94%

Pre-Market 08:30 PM

61.87

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

SciSparc Ltd. (SPRC) stock declined over -4.30%, trading at $4.23 on NASDAQ, down from the previous close of $4.42. The stock opened at $4.53, fluctuating between $4.19 and $4.89 in the recent session.

Stock Snapshot

4.42

Prev. Close

244.66K

Market Cap

4.19

Day Low

N/A

P/E Ratio

3156.52

EPS (TTM)

-8.33

Cash Flow per Share

4.53

Open

57.84K

Number of Shares

4.89

Day High

99.79%

Free Float in %

10.77

Book Value

1.97M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 20, 2026	4.53	5.20	4.19	4.23	716.85K
Apr 17, 2026	4.24	4.69	3.98	4.42	66.52K
Apr 16, 2026	3.42	4.61	3.40	4.24	237.01K
Apr 14, 2026	3.16	3.32	3.11	3.23	7.27K
Apr 13, 2026	3.09	3.13	2.98	3.07	9.28K
Apr 10, 2026	3.11	3.15	2.98	3.15	15.32K
Apr 09, 2026	3.35	3.35	3.03	3.06	10.5K
Apr 08, 2026	3.56	3.56	3.32	3.42	3.18K
Apr 07, 2026	3.44	3.56	3.30	3.32	5.14K
Apr 06, 2026	3.48	3.61	3.48	3.59	6.32K
Apr 02, 2026	3.67	3.67	3.37	3.54	10.42K
Apr 01, 2026	3.75	3.95	3.59	3.66	4.15K
Mar 31, 2026	3.59	3.72	3.50	3.66	6.15K
Mar 30, 2026	3.81	3.84	3.51	3.60	26.75K
Mar 27, 2026	3.95	4.17	3.67	3.91	5.59K
Mar 25, 2026	4.21	4.51	4.20	4.25	6.34K
Mar 24, 2026	4.40	4.51	4.34	4.35	11.67K
Mar 23, 2026	4.40	4.66	4.40	4.52	7.72K
Mar 20, 2026	4.34	4.63	4.20	4.63	5.68K
Mar 19, 2026	4.63	4.72	4.47	4.66	8.5K

Contact Details

Tel Aviv, 6971916

Israel

https://scisparc.com 972 371 5777

About Company

SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and epilepsy. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in soft gel capsule form. It also has an agreement with the Sheba Fund for Health Services and Research to examine the potential role of SCI-210 for the treatment of status epilepticus; and The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.

Stock Peers

ARGX

-14.59-1.72%

argenx SE$834.45 REGN

-1.16-0.15%

Regeneron Pharmaceuticals, Inc.$749.41 UTHR

-14.94-2.54%

United Therapeutics Corporation$573.44 MDGL

-4.91-0.92%

Madrigal Pharmaceuticals, Inc.$527.11 VRTX

-2.02-0.46%

Vertex Pharmaceuticals Incorporated$439.18 PRAX

0.07+0.02%

Praxis Precision Medicines, Inc.$342.57 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

1.28+0.41%

Alnylam Pharmaceuticals, Inc.$310.94 KRYS

2.29+0.84%

Krystal Biotech, Inc.$276.50 ASND

0.9+0.37%

Ascendis Pharma A/S$245.38

Company Overview

SciSparc Ltd. (NASDAQ:SPRC) closed at $4.23 USD, losing -$0.19 (-4.30%) from the previous close of $4.42. The stock is currently mid-range between its 52-week high and low $2.98 and $94.50. With a market capitalization of about $244.66 thousand, SciSparc Ltd. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.33). Key stats such as the average daily volume over the past year has been around 147.65 thousand shares, trading with heavier-than-usual volume. Headquartered in Tel Aviv, None, SciSparc Ltd. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Oz Adler, the company employs approximately 2 people and listed since August 30, 2021. SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules.

Technical Performance

SPRC has shown weak momentum, losing -24.14% over the past week and -71.2% over the past quarter, though year-to-date performance is down -19.12%. Short-term trend indicators are bullishly aligned (SMA20 -7.07%, SMA50 -43.35%, SMA200 -84.65%). The stock’s 14-day RSI is 29.32 (weak momentum), while the ATR of 0.08 points to moderate volatility. The stock remains hovering near 52-week lows, trading -94.58% below its high and over 20.06% above its low. Average 10-day trading volume of 207.39 thousand shares is slightly above the 3-month average of 183.78 thousand, indicating heightened recent market interest.

Valuation Metrics

SciSparc Ltd. trades at a P/E ratio of -0.02, slightly below the S&P 500 average, with a price-to-sales ratio of 0.27 and a price-to-book ratio of -0.33 indicating negative book value, which may reflect financial stress. The P/FCF stands at -0.05, also above market averages.

Dividend & Fair Value

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Earnings & Analyst Outlook

SciSparc Ltd. generated EPS of -$23.43 over the past year. Five-year average earnings growth is -8.23%.

Shareholding & Insider Activity

SciSparc Ltd. has 534.61 thousand shares outstanding. The public float is 514.58 thousand shares, elevated short interest at 2.14% of float. This equals 11.37 thousand shares. The short ratio is 0.28 days. Institutional investors hold 1.23% of the float. Insiders own 8.56%.

Financial & Profitability Overview

Over the trailing twelve months, SciSparc generated $2.88M in revenue, or $7.06 per share. Gross margin was 76.28%, operating margin -200.52%, and net profit margin -177.91%. Returns are negative, with ROA at -45.81% and ROE at -67.27%.
On valuation metrics, SciSparc trades at a P/E of -0.02, P/S of 0.27 and P/B of -0.33. Liquidity is tight, with a current ratio of 0.55 and quick ratio of 0.52. Operationally, the company’s inventory turnover is 4.70 and cash conversion cycle is 75.45 days. Debt-to-equity is -3.14, supported by a cash flow-to-debt ratio of -1.94.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, SciSparc posted revenue of $2.88M, down slightly from $1.35M in the prior quarter. Gross profit was $2.20M (margin 76.28%). Operating income was - $5.77M (margin -200.5%). Net income was- $5.12M (EPS - $12.55).
The company ended the quarter with $5.14M in cash and short-term investments, a total debt of $76.00K, and net debt of - $2.07M. Total assets were $11.18M, with equity of $9.59M. Financials further reflected weakness, with operating cash flow of - $5.89M, free cash flow of - $5.89M, and capital expenditures of $0.00.

Price Forecast & Outlook

Our AI price prediction model suggests that SciSparc Ltd. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 13.0%, with price expected at $4.78 by May 04, 2026, within a range of $3.14 to $6.46 3-Month Outlook: Projected rise of 285.82%, reaching $16.32 by July 17, 2026, with a range of $8.51 to $17.17. 1-Year Outlook: Projected loss of -80.85%, with price at $0.81 by April 20, 2027, within a range of $0.00 to $5.61.

Key Takeaways

SciSparc Ltd. (NASDAQ:SPRC) shares are down -19.12% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows SciSparc Ltd. trading at a premium to the broader market with a P/E of -0.02. Our AI forecast model points to short-term strength (13.0% over two weeks), a medium-term rise (285.82% over three months), and a longer-term loss (-80.85% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current SciSparc Ltd. (SPRC) stock price?

SciSparc Ltd. (NASDAQ: SPRC) stock price is $4.23 in the last trading session. During the trading session, SPRC stock reached the peak price of $4.89 while $4.19 was the lowest point it dropped to. The percentage change in SPRC stock occurred in the recent session was -4.3% while the dollar amount for the price change in SPRC stock was - $0.19.

SPRC's industry and sector of operation?

The NASDAQ listed SPRC is part of Biotechnology industry that operates in the broader Healthcare sector. SciSparc Ltd. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SPRC?

Mr. Oz Adler C.P.A.
Chief Executive Officer & Chief Financial Officer
Dr. Adi Zuloff-Shani Ph.D.
Chief Executive Officer
Mr. Itschak Shrem
Pres & Director
Mr. Oz Adler CPA
Chief Executive Officer & Chief Financial Officer

How SPRC did perform over past 52-week?

SPRC's closing price is 41.95% higher than its 52-week low of $2.98 where as its distance from 52-week high of $94.50 is -95.52%.

How many employees does SPRC have?

Number of SPRC employees currently stands at 2.

Link for SPRC official website?

Official Website of SPRC is: https://scisparc.com

How do I contact SPRC?

SPRC could be contacted at phone 972 371 5777 and can also be accessed through its website. SPRC operates from Tower A, Tel Aviv, 6971916, Israel.

How many shares of SPRC are traded daily?

SPRC stock volume for the day was 1.97M shares. The average number of SPRC shares traded daily for last 3 months was 147.65K.

What is the market cap of SPRC currently?

The market value of SPRC currently stands at $244.66K with its latest stock price at $4.23 and 57.84K of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	2
Beta	1.28
Sales or Revenue	$2.88M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

SPRC Company Profile and Key Details

SciSparc

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Shareholding & Insider Activity

Earnings & Analyst Outlook

Price Forecast & Outlook

Key Takeaways

Financial & Profitability Overview

Quarterly Financial Highlights